Adverse incidents: in vitro diagnostic (IVD) blood glucose meters
- Medicines and Healthcare products Regulatory Agency
- Part of:
- Medical devices: guidance for manufacturers on vigilance, Patient safety, Medical devices regulation and safety, and Vigilance, safety alerts and guidance
- First published:
- 26 January 2015
For manufacturers reporting adverse incidents with IVD blood glucose meters under the European vigilance system.
PDF, 53KB, 2 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
Guidance on how to report adverse incidents with IVD blood glucose meters for point of care testing or home use. You need to read this alongside the European Commission’s guidelines on the vigilance system for medical devices.
Published: 26 January 2015